Takeda's Easily Dissolved Actos Approved In Japan For Diabetics
This article was originally published in PharmAsia News
Executive Summary
Japan regulators gave marketing approval to Takeda Pharmaceutical's Actos (pioglitazone) diabetes drug in a tablet form that dissolves in saliva without the need to take it with water